HIVRelatedCancers News

CancerConsultants provides summaries of new treatment strategies as they are discovered and reported by cancer physicians around the world. Our medical staff attends medical meetings worldwide and reviews medical literature daily to ensure appropriate news is provided to cancer patients and their families in a timely manner.

News of the results of recent clinical trials evaluating cancer therapies and supportive care strategies serve to educate patients regarding new treatment strategies for cancer and facilitate discussions with their doctor. Development of new cancer treatments usually begins in patients with recurrent or metastatic cancers. Once the new treatment appears effective, it is applied to earlier stages of the disease or to patients at higher risk of treatment failure.

Share

HIVRelatedCancers News


Simple Tips to Improve Your Sleep Habits (August 26, 2016)

By Teofilo L. Lee-Chiong Jr., MD Getting Regular Sleep Isn’t Easy. Work demands, worries about finances or family, or a busy schedule can push back your bedtime. According to a re­cent nationwide study... Continue Reading

Cancer Survivorship: Anxiety, Stress, and Depression (August 26, 2016)

By Barrie Cassileth, MS, PhD Cancer inevitably stirs up many feelings. It’s normal to become anxious or stressed-out, and many patients and family members face feelings of depression. Help is, however,... Continue Reading

For a Healthy Heart, #GoRedGetFit (August 26, 2016)

A social media initiative aims to educate and inspire positive change in diet and exercise habits and to promote heart health among multicultural women. By Diana Price For renowned personal trainer and... Continue Reading

Getting Started With Yoga (August 26, 2016)

New to yoga? Roll out your mat with confidence by putting these 12 tips into practice. By Jessica Matthews, MS, E-RYT 500 While yoga offers a plethora of research-supported physiological and psychological... Continue Reading

Keytruda® Approved for Advanced Head and Neck Cancer (August 24, 2016)

The United States Food and Drug Administration (FDA) has approved Keytruda® (pembrolizumab) for the treatment of advanced head and neck cancer that has stopped responding to platinum-based chemotherapy... Continue Reading

SGO, ASCO Issue New Guidelines for Ovarian Cancer Treatment (August 22, 2016)

A new joint clinical practice guideline from the American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology (SGO) states that neoadjuvant chemotherapy (NACT) is the optimal first-line... Continue Reading

Pancreatic Cancer Cells Find Unique Fuel Sources to Keep from Starving (August 17, 2016)

Pancreatic cancer cells avert starvation in dense tumors by ordering nearby support cells to supply them with an alternative source of nutrition. This is the finding of a study in cancer cells and mice... Continue Reading

Opdivo® Highly Effective for Some Patients with Lymphomas (August 16, 2016)

The immunotherapeutic agent, Opdivo® (nivolumab), appears to provide long-lasting anti-cancer activity among some patients who have received extensive prior therapy for both B- and T-cell lymphomas. These... Continue Reading

Midlife PSA Levels Correlate to Risk of Future Lethal Prostate Cancer (August 15, 2016)

A baseline prostate-specific antigen (PSA) level among men at midlife appears to be highly correlated with the risk of developing lethal prostate cancer within their lifetimes. These results were recently... Continue Reading

T-Cells Can be Directed to Treat a Variety of Ovarian Cancers (August 11, 2016)

With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the... Continue Reading

More HIVRelatedCancers News

Latest HIVRelatedCancers News By Stage

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS